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Prenatal Diagnosis of Transient Abnormal
Myelopoiesis in a Down Syndrome Fetus
We report a case of transient abnormal myelopoiesis in a Down syndrome fetus
diagnosed at 28
+3 weeks of gestation that rapidly progressed to intrauterine death
10 days later. Fetal hepatosplenomegaly with cerebral ventriculomegaly,
although not specific, may be a suggestive finding of Down syndrome with tran-
sient abnormal myelopoiesis. Prompt fetal blood sampling for liver function test
and chromosomal analysis are mandatory for early detection and management.
ransient abnormal myelopoiesis (TAM) occurs in about 10% of newborns
with Down syndrome, but prenatal diagnoses of fetal TAM has been
rarely documented. Suspicion of this disorder arises when fetal
hepatosplenomegaly with or without fetal hydrops is detected by prenatal ultrasonog-
raphy (1-3). Percutaneous umbilical cord blood sampling is needed to diagnose TAM
prenatally. Hematologic characteristics of TAM are markedly increased leukocyte
level with blast cells in peripheral blood, which usually disappears spontaneously
within a couple of months. Hepatosplenomegaly in TAM is thought to result from
hepatic invasion of blast cells and/or secondary hepatic fibrosis (1). Hepatic failure
and/or heart failure, and true leukemic change have been suggested as the main cause
of death in fetuses with TAM (4). Here we present a report of fetal TAM in Down
syndrome that resulted in a fatal outcome.
CASE REPORT
A 32-year-old Korean woman (gravida 3, para 2) was referred to our hospital at 28
+3
weeks of gestation because of suspected fetal hepatomegaly. The course of this
pregnancy had been uneventful. Her previous two pregnancies had resulted in full-
term, uncomplicated vaginal births.
Transabdominal ultrasonogram and Doppler examination with a 4-MHz convex
transducer (GE Kretzvolusom730, NY) were performed on referral. Decreased
amniotic fluid (amniotic fluid index, 5) and a hydropic placental change were noted
(maximum thickness, 6.2 cm). By biometry, the head circumference was demonstrated
as being between 90 and 97 percentile size and the femur length was normal for
gestational age, but abdominal circumference was increased due to
hepatosplenomegaly (34.3 mm, larger than 97%) (5). A hypoechoic liver occupied
nearly the entire enlarged abdomen and the length of liver was 7.2 cm (90th
percentile) (6) (Fig. 1A). The stomach could not be detected and mild cerebral
ventriculomegaly (1.1 cm) was demonstrated (Fig. 1B). The cardio-thoracic circumfer-
ence ratio (62%) increased but cardiac anatomy was normal. No other structural
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Fig. 1. Transient abnormal myelopoiesis in Down syndrome fetus.
A. Longitudinal ultrasound scan of fetal abdomen shows
hypoechoic liver occupying nearly entire enlarged abdomen. 
Liver length of 7.2 cm represents 90th percentile size. 
B. Fetal cerebral ventriculomegaly measuring 1.1 cm is evident. 
C. Oblique ultrasound scan of fetal abdomen. Skin edema (→) and
ascites (*) are evident at 29
+4 weeks’ gestation. 
D. Postmortem picture of fetus with hepatomegaly.
E. Myeloblastic cells infiltrating bone marrow (Hematoxylin & Eosin
staining, ×40 magnification).
Eabnormality was detected. 
The peak systolic velocity (PSV) of the middle cerebral
artery (MCA) increased (64.2 cm/s). Doppler flow patterns
of all other vessels (uterine arteries, umbilical artery,
umbilical vein, ductus venosus, inferior vena cava and four
cardiac valves) were normal.
Percutaneous umbilical cord blood sampling (PUBS) was
performed on the same day. The results are shown in
Table 1. All serologic markers for intrauterine infection
were negative (Toxoplasmosis, Cytomegalovirus, Herpes
simplex, Rubella, Varicella Zoster, Epstein-Barr virus,
Parvoviurs B19). The fetal blood count showed marked
leukocytosis with 82% blast cells, moderate anemia and
thrombocytopenia. Liver enzymes were markedly
elevated. Fetal karyotyping revealed a trisomy 21
(47,XX,+21).
A follow up ultrasonography at 29
+4 weeks’ gestation
revealed moderate amounts of ascites, pericardial effusion
and skin edema (Fig. 1C). The PSV of the MCA further
increased to 80.2 cm/s. Doppler velocimetry of other
vessels including the umbilical artery, umbilical vein,
ductus venosus and inferior vena cava revealed no
abnormal findings. Subsequent fetal heart rate tracing
showed minimal variability with shallow deceleration and
fetal death in utero was diagnosed at 29
+6 weeks’ gestation. 
Postmortem examination showed generalized cutaneous
edema with pericardial effusion and ascites. Fetal nasal
root was wide and flat. There were marked hepatomegaly
(170 g; normal, 40±22 g) and splenomegaly (20 g; normal,
3.1±1.5 g) (7) (Fig. 1D). No other congenital malforma-
tions were detected and the placenta was hydropic with
immature villi. Bone marrow was infiltrated with
myeloblastic cells (Fig. 1E).
DISCUSSION
The association of Down syndrome and leukemia has
been documented for over 50 years. Multiple studies have
established the incidence of leukemia in Down syndrome
patients to be 10-20-fold higher than that in the general
population (8). About 10% of infants with Down
syndrome have characteristic transient leukemoid reaction
that disappears spontaneously within several months,
therefore, this disorder has been designated TAM or
congenital leukemoid reaction (9). Markedly elevated
leukocyte levels together with circulating blast cells are
characteristic hematological changes of an infant or fetus
with TAM (2). Hemoglobin concentration is usually normal
in TAM, but can be polycythemic (10) or anemic (1, 11).
Our case showed a blood cell count that was moderately
anemic, which was reflected as increased PSV of the MCA
(12, 13). 
Hepatosplenomegaly is a characteristic ultrasonographic
sign for fetal TAM (1, 4, 11, 14, 15). Only one case of fetal
TAM without hepatosplenomegaly has been reported (16).
Our case showed marked hepatosplenomegaly on first
ultrasonography, and fetal hydrops was evident on follow
up ultrasonography. Hepatomegaly in TAM is thought to
result from liver fibrosis, infiltration of blast cells to the
liver and portal hypertension (1, 2). However, fetal
hepatomegaly is a non-specific finding which can be associ-
ated with various conditions such as fetal anemia, congeni-
tal fetal infection, hepatic tumors, metabolic disorders,
fetal congestive heart failure and macrosomia (3). So,
umbilical cord blood sampling should be performed for
differential diagnosis.
Ultrasonographic echogenicity of the enlarged liver in
our fetus was markedly hypoechoic compared with
meconium inside the colon, which is a characteristic finding
in most fetuses with TAM. The mechanism for
hypoechogenicity of the liver in TAM is not clear, but
hepatic congestion secondary to increased extramedullary
myelopoiesis of fetal liver has been suggested (3, 4, 14).
Hepatic dysfunction of enlarged fetal liver was present in
our case as in most fetuses with TAM (1, 10, 11, 15), which
might be associated with liver fibrosis (1-4). In our case,
the stomach shadow was not detected by ultrasound
examination but postmortem study confirmed the normal
stomach. Small or absent stomach shadow is presumed to
be the result of collapse by enormous hepatosplenomegaly.
Presently, there was mild cerebral ventriculomegaly, which
is a characteristic ultrasonographic marker for Down
syndrome (17). To our knowledge, of the 41 fetuses with
TAM including our case that have been reported in the
literature, only three fetuses with ventriculomegaly (9-11
mm) have been documented (2, 15). Although we did not
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Table 1. Hematologic Values Obtained by Percutaneous
Umbilical Cord Blood Sampling
Hematologic Test Case Normal Values* 
Complete blood counts (19)
White blood cells (109/L) 146.7 004.44 ± 0.850 0
Blast cells (%) 82 0
Hemoglobin (g/dL) 8.8 013.35 ± 1.170 0
Hematocrit (%) 025 041.54 ± 3.310 0
Platelets (109/L) 165 253.54 ± 36.60 0
Liver function test (20)
Lactate dehydrogenase (U/L) 3,596 259 - 552
Aspartate aminotransferase (U/L) 125 09 - 31
Alanine aminotransferase (U/L) 130 01 - 15
Note.─ * References 19 and 20perform a brain autopsy of the fetus, postmortem examina-
tion of the other two fetuses revealed brain atrophy with
periventricular leukomalacia (2, 15). The pathogenesis of
ventriculomeglay in fetuses with TAM appears to be differ-
ent from that in Down syndrome fetuses without TAM. It
seems that ventriculomegaly in Down syndrome fetuses
may result from reduced brain tissue secondary to altered
neuronal cell divisions early in developmental stage (18).
However, ventriculomegaly in fetuses with TAM is
thought to result from leukemic infiltration or local
hypoxemia secondary to leukostasis (15). This can partly
explain why fetal cardiotocogram shows minimal variabil-
ity and/or late deceleration in all cases with subtle
ventriculomegaly (2, 15). Fetal hydrops is another
common ultrasonographic finding in TAM fetuses, which
may be associated with a poorer prognosis (1). Numerous
theories have been proposed regarding the pathogenesis of
fetal hydrops; anemia that results in high output cardiac
failure, congestive heart failure due to increased vascular
resistance, local hypoxia secondary to leukostasis, portal
venous hypertension due to hepatic enlargement, capillary
damage by hypoxia, fetal hypoalbuminemia, increased
vascular resistance, extramedullary megakaryoblastic
proliferation, hepatic fibrosis and increased collagen
synthesis by fibroblasts stimulated through cytokines (1-3).
In conclusion, fetal hepatosplenomegaly with cerebral
ventriculomegaly, although not specific, may be a sugges-
tive finding of Down syndrome with TAM. Prompt fetal
blood sampling for liver function test and chromosomal
analysis are mandatory for the early detection and
planning of management. In addition, because ventricu-
lomegaly as well as fetal hydrops may have poor prognos-
tic implications, we suggest that ventriculomegaly should
be recognized in the management of fetal TAM.
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